MedTrace Logo

COPD at a Street Level

NCT05660460 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 511

Last updated 2024-04-09

No results posted yet for this study

Summary

The trial investigates and describes the prevalence of COPD among socially vulnerable individuals who come in contact with a mobile clinic and investigates the effect of opportunistic screening for COPD in these vulnerable persons. The study population is individuals who come in contact with a mobile clinic, that visits home shelters, open drugs scenes etc. in the Capital Region of Denmark during the inclusion period, and monitor them for up to 1 year in order to investigate variables that are significant in terms of the patients' treatment, hospitalizations, and mortality in relation to COPD. Our hypothesis is that there will be a higher incidence of COPD among socially vulnerable individuals who come in contact with the mobile clinic than in the general population.

Conditions

Interventions

DIAGNOSTIC_TEST

Spirometry

The method of examination, Spirometry, is noninvasive (i.e. not an intervention that involves penetration into the body by means of incisions or injections.). It is a routine examination and there are no risks, adverse reactions, or discomforts associated with the examination.

Sponsors & Collaborators

  • Brugernes Akademi

    collaborator UNKNOWN

  • Hvidovre University Hospital

    lead OTHER

Principal Investigators

  • Jannet van der Veen · Brugernes Akademi

  • Charlotte S Ulrik · Amager and Hvidovre Hospital

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-15
Primary Completion
2027-03-15
Completion
2029-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05660460 on ClinicalTrials.gov